Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

A child with low platelets and anemia was later found to have lupus.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

SLE and DM can coexist but are rare and need careful evaluation.

Fever and rash can be early signs of lupus.

Nails can reveal important health information about skin and body conditions.

Oral ulcers are common in SLE patients and often link to other symptoms.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).